Abstract:Imidazole alkaloids, a common class of five-membered aromatic heterocyclic compounds, exist widely in plants, animals and marine organisms. Because of imidazole's extensive and excellent biological and pharmacological activities, it has always been a topic of major interest for researchers and has been widely used as an active moiety in search of bioactive molecules. To find more efficient antibacterial compounds, a series of novel imidazole-fragment-decorated 2-(pyrazol-4-yl)-1,3,4-oxadiazoles were designed and synthesized based on our previous works via the active substructure splicing principle, and their bioactivities were systematically evaluated both in vitro and in vivo. The bioassays showed that some of the target compounds displayed excellent in vitro antibacterial activity toward three virulent phytopathogenic bacteria, including Xanthomonas oryzae pv. oryzae (Xoo), Xanthomonas axonopodis pv. citri (Xac) and Pseudomonas syringae pv. actinidiae (Psa), affording the lowest EC50 values of 7.40 (7c), 5.44 (9a) and 12.85 (9a) μg/mL, respectively. Meanwhile, compound 7c possessed good in vivo protective and curative activities to manage rice bacterial leaf blight at 200 μg/mL, with control efficacies of 47.34% and 41.18%, respectively. Furthermore, compound 9a showed commendable in vivo protective and curative activities to manage kiwifruit bacterial canker at 200 μg/mL, with control efficacies of 46.05% and 32.89%, respectively, which were much better than those of the commercial bactericide TC (31.58% and 17.11%, respectively). In addition, the antibacterial mechanism suggested that these new types of title compounds could negatively impact the cell membranes of phytopathogenic bacteria cells and cause the leakage of the intracellular component, thereby leading to the killing of bacteria. All these findings confirm that novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles containing an imidazole fragment are promising lead compounds for discovering new bactericidal agents.

Synthesis of Thiazolium-Labeled 1,3,4-Oxadiazole Thioethers As Prospective Antimicrobials: in Vitro and in Vivo Bioactivity and Mechanism of Action

Integration of Naturally Bioactive Thiazolium and 1,3,4-Oxadiazole Fragments in a Single Molecular Architecture As Prospective Antimicrobial Surrogates

Rational design, synthesis, and antimicrobial evaluation of novel 1,2,4-trizaole-substituted 1,3,4-oxadiazole derivatives with a dual thioether moiety

Rational Optimization and Action Mechanism of Novel Imidazole (or Imidazolium)-Labeled 1,3,4-Oxadiazole Thioethers as Promising Antibacterial Agents against Plant Bacterial Diseases.

Design, Synthesis, and Antimicrobial Behavior of Novel Oxadiazoles Containing Various N-containing Heterocyclic Pendants

Novel 1,3,4-Oxadiazole Thioether and Sulfone Derivatives Bearing a Flexible N-Heterocyclic Moiety: Synthesis, Characterization, and Anti-microorganism Activity

Design, Synthesis and Antimicrobial Activities of Novel 1,3,5-Thiadiazine-2-thione Derivatives Containing a 1,3,4-Thiadiazole Group

Novel quinazolin-4(3H)-one derivatives containing a 1,3,4-oxadiazole thioether moiety as potential bactericides and fungicides: Design, synthesis, characterization and 3D-QSAR analysis

Synthesis and Antibacterial Evaluation of Novel 1,3,4-Oxadiazole Derivatives Containing Sulfonate/Carboxylate Moiety.

Synthesis and Bioactivities of Novel 2-(Thioether/sulfone)-5-pyrazolyl-1,3,4-oxadiazole Derivatives

Synthesis, Bioactivities, and Antibacterial Mechanism of 5-(Thioether)-n-phenyl/benzyl-1,3,4-oxadiazole-2-carboxamide/amine Derivatives.

Design, Synthesis, and Bioactivity Evaluation of Novel 1,3,4-Thiadiazole Sulfone-Derived Compounds Incorporating an Amide Moiety as Active Antibacterial Agents

Synthesis and Antibacterial Evaluation of New Sulfone Derivatives Containing 2-Aroxymethyl-1,3,4-Oxadiazole/Thiadiazole Moiety.

Design and Synthesis of New 2-Aryl-4,5-dihydro-thiazole Analogues: in Vitro Antibacterial Activities and Preliminary Mechanism of Action

Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents

Synthesis and antibacterial activity of pyridinium-tailored 2,5-substituted-1,3,4-oxadiazole thioether/sulfoxide/sulfone derivatives.

Synthesis and Investigation of the Antibacterial Activity and Action Mechanism of 1,3,4-Oxadiazole Thioether Derivatives.

Synthesis and antibacterial activity of oxime ester derivatives containing 1,2,4-triazole or 1,3,4-oxadiazole moiety

Synthesis and in Vitro and in Vivo Biological Activity Evaluation and Quantitative Proteome Profiling of Oxadiazoles Bearing Flexible Heterocyclic Patterns

Synthesis and Evaluation of 1,3,4‐thiadiazole Derivatives Containing Cyclopentylpropionamide As Potential Antibacterial Agent

Synthesis and Antimicrobial Activity of Novel 2-Substituted Phenoxy-N-(4-Substituted Phenyl-5-(1h-1,2,4-Triazol-1-Yl)Thiazol-2-Yl)Acetamide Derivatives